Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study.
Yegya-Raman N, Plastaras JP, Wright CM, Chelius M, Zhang S, Baron JA, Hubbeling H, Sim AJ, Robinson TJ, Jain MD, Imber B, Fregonese B, Yahalom J, Ladbury C, Dandapani S, Pinnix CC, Gunther JR, Fang PQ, Wu SY, Dabaja BS, Yang JC, Chew J, Braunstein S, Sinha S, Delinger NM, Sun S, Terezakis SA, Sakthivel G, Constine LS, Chowdhry AK, Reagan PM, Burke S, Tseng YD, LaRiviere MJ, Maity A, Schuster SJ, Chong EA, Figura NB.
Yegya-Raman N, et al. Among authors: gunther jr.
Blood Adv. 2025 Jul 8;9(13):3293-3303. doi: 10.1182/bloodadvances.2025015855.
Blood Adv. 2025.
PMID: 40203192
Free PMC article.